Hydroxychloroquine Sulfate
Antimalarial / Disease-Modifying Anti-Rheumatic Drug (DMARD)
CONTENTS:
Each film-coated tablet contains 200 mg of Hydroxychloroquine Sulfate​
INDICATIONS:
-
Adults: Treatment of rheumatoid arthritis, discoid and systemic lupus erythematosus, and dermatological conditions caused or aggravated by sunlight
-
Pediatric population: Treatment of juvenile idiopathic arthritis (in combination with other therapies), discoid and systemic lupus erythematosus
CONTRAINDICATIONS:
-
Hydroxychloroquine Sulfate tablets are contraindicated for patients known to have hypersensitivity to 4-aminoquinoline compounds
-
Hydroxychloroquine Sulfate tablets should not be administered to patients with pre-existing maculopathy of the eye
-
Hydroxychloroquine Sulfate tablets should not be administered during pregnancy
DOSAGE:
-
Adults (including elderly): The minimum effective dose should be employed. This dose should not exceed 6.5 mg/kg/day (calculated from ideal body weight and not actual body weight) and will be either 200 mg or 400 mg per day
-
In patients able to receive 400 mg daily: Initially 400 mg daily in divided doses. The dose can be reduced to 200 mg when no further improvement is evident. The maintenance dose should be increased to 400 mg daily if the response lessens.
-
Pediatric Population: The minimum effective dose should be employed and should not exceed 6.5 mg/kg/day based on ideal body weight
​
​
AVAILABILITY:
Box of 30's